Covista (CVSA) Investor Day 2026 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 summary
16 Apr, 2026Strategic vision and market positioning
Rebranded as Covista, aiming to dominate the intersection of healthcare and education with a portfolio of five accredited institutions, deep clinical partnerships, and a multi-institution platform spanning medicine, nursing, veterinary, and behavioral sciences.
Positioned as America's largest healthcare educator, serving 24,000 healthcare graduates annually and over 290,000 alumni nationwide, with a focus on addressing the U.S. healthcare workforce crisis through scale, integration, and technology-enabled solutions.
Introduced the 'Purpose at Scale' strategy, emphasizing ambitious growth via new programs, geographies, brands, and employer integration, while targeting underserved populations and nontraditional students.
AI and digital innovation are central, with heavy investment in partnerships and over 20 AI-powered solutions deployed to personalize education and transform care delivery.
Deep clinical relationships, regulatory expertise, and partnerships with healthcare employers create high barriers to entry and support long-term demand.
Financial guidance and capital allocation
Exceeded previous three-year investor targets ahead of schedule, achieving record enrollment, margin expansion, and robust organic growth across cycles.
FY26 revenue guidance is $1.9–$1.94 billion with adjusted EPS of $7.80–$8.00; FY29 targets include over 120,000 enrolled students, 7%-10% revenue CAGR, and 10%-14% adjusted EPS CAGR from FY26 levels.
Strong cash generation, reduced net leverage to 0.9x, and $936 million returned to shareholders since Q3 FY22, with a disciplined capital allocation strategy supporting organic growth, M&A, and share repurchases.
Investments in 10-15 new Chamberlain campuses by 2029 are included in guidance, each expected to be EBITDA positive within two years and payback by year 3-5.
No M&A is factored into current projections, but share repurchases are modeled in, maintaining flexibility for future opportunities.
Institutional performance and growth drivers
Walden University regained leadership in graduate-focused online education, doubled undergraduate enrollment, and targets over 65,000 enrollment by FY29, with strong digital innovation and program expansion.
Medical and veterinary schools are leading U.S. producers of Black physicians and veterinarians, with over 6,000 enrollment target by FY29, filling workforce gaps in underserved geographies and primary care.
Chamberlain University is the largest U.S. nursing school, targeting over 49,000 enrollment by FY29, leading in both pre- and post-licensure nursing, and expanding BSN programs.
AI-driven student experience improvements have increased enrollment, persistence, and NPS, while reducing acquisition costs by 16% and driving a 20% increase in organic inquiries.
Strategic partnerships with healthcare systems and employers enhance talent pipelines and workforce readiness.
Latest events from Covista
- Raised EPS guidance, strong enrollment, and $750M buyback drive robust financial results.CVSA
Q2 20263 Feb 2026 - Double-digit enrollment and earnings growth in FY24, with robust FY25 outlook.CVSA
Q4 20242 Feb 2026 - Record enrollment and margin gains highlight leadership in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Double-digit revenue and enrollment growth led to higher earnings and raised FY25 guidance.CVSA
Q1 202518 Jan 2026 - Double-digit growth in revenue, enrollment, and EPS, with raised 2025 guidance and lower leverage.CVSA
Q2 20259 Jan 2026 - Record financial and academic results, with strong governance and pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - FY2024 saw record growth, strong diversity, and robust pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and hold say-on-pay vote in November 2025.CVSA
Proxy Filing1 Dec 2025 - Record FY25 growth and strong FY26 outlook, driven by enrollment and partnerships.CVSA
Q4 202523 Nov 2025